GSK plc
GS7.DE
Get informed when a big investor buys or sells
+ FollowMarket Cap$101.55B
Close$
Share Statistics
| Market cap | $101.55 Billion |
|---|---|
| Enterprise Value | $116.60 Billion |
| Dividend Yield | $0.77 (3.89%) |
| Earnings per Share | $1.41 |
| Beta | 0.25 |
| Outstanding Shares | 4,023,000,000 |
Return
| Return on Equity | 86.80% |
|---|---|
| Return on Assets | 24.81% |
| Return on Invested Capital | 46.40% |
Valuation & Multiples
| P/E Ratio | 14.58 |
|---|---|
| PEG | -20.92 |
| Price to Sales | 0.28 |
| Price to Book Ratio | 5.15 |
| Enterprise Value to Revenue | 0.39 |
| Enterprise Value to EBIT | 6.29 |
| Enterprise Value to Net Income | 7 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 1.03 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Glaxosmithkline plc
66,841 employees
CEO: Emma Walmsley GSK plc, a global healthcare and pharmaceutical leader with roots tracing back to 1715, is headquartered in Brentford, United Kingdom. Operating extensively across the UK, United States, and other international markets, its activities sp...